These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6030491)

  • 21. Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Jan; 12(1):104-7. PubMed ID: 5763003
    [No Abstract]   [Full Text] [Related]  

  • 22. Irreversible enzyme inhibitors. CXXXVII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 6-(p-aminomethylphenoxymethyl)-2,4-diamino-5-(3,4-dichlorophenyl)pyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):86-8. PubMed ID: 5763047
    [No Abstract]   [Full Text] [Related]  

  • 23. Irreversible enzyme inhibitors. CXXXIX. p-(4,6-Diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)phenylpropionylsulfanilyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase. VI. Further studies on effects of substitution on the propionamide bridge on isozyme specificity.
    Baker BR; Lourens GJ
    J Med Chem; 1969 Jan; 12(1):92-4. PubMed ID: 5763049
    [No Abstract]   [Full Text] [Related]  

  • 24. Enzyme inhibitors. XV. A new irreversible inhibitor of adenosine deaminase.
    Schaeffer HJ; Odin E
    J Med Chem; 1967 Mar; 10(2):181-3. PubMed ID: 6068034
    [No Abstract]   [Full Text] [Related]  

  • 25. Analogs of tetrahydrofolic acid 34. Hydrophobic bonding to dihydrofolic reductase VI. Mode of phenyl binding of some 6-arylpyrimidines.
    Baker BR; Shapiro HS
    J Pharm Sci; 1966 Mar; 55(3):308-17. PubMed ID: 5960177
    [No Abstract]   [Full Text] [Related]  

  • 26. Irreversible enzyme inhibitors. 108. 6-(p-chloroacetylanilinomethyl)-5-(p-chlorophenyl)-2,4-diaminopyrimidine, an active-site-directed irreversible inhibitor of dihydrofolic reductase.
    Baker BR; Huang PC; Pogolotti AL
    J Med Chem; 1967 Nov; 10(6):1134-8. PubMed ID: 6056043
    [No Abstract]   [Full Text] [Related]  

  • 27. Irreversible enzyme inhibitors. CLIX. Effect of substitution on transport and isozyme specificity of p-(4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazin-1-yl)-o-chlorophenoxyacetamido-benzenesulfonyl fluoride, an active-site-directed irreversible inhibitor of dihydrofolic reductase.
    Baker BR; Ashton WT
    J Med Chem; 1969 Sep; 12(5):894-7. PubMed ID: 5812207
    [No Abstract]   [Full Text] [Related]  

  • 28. Irreversible enzyme inhibitors. CLXVI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 2,4-diamino-5(3,4-dichlorophenyl)pyrimidine with 6 substituents and some factors in their cell wall transport.
    Baker BR; Vermeulen NM
    J Med Chem; 1970 Jan; 13(1):82-6. PubMed ID: 5460895
    [No Abstract]   [Full Text] [Related]  

  • 29. Irreversible enzyme inhibitors. CLIV. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-substituted 2,4-diaminopyrimidines.
    Baker BR; Meyer RB
    J Med Chem; 1969 Jul; 12(4):668-71. PubMed ID: 5793159
    [No Abstract]   [Full Text] [Related]  

  • 30. Irreversible enzyme inhibitors. CLX. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines.
    Baker BR; Janson EE; Vermeulen NM
    J Med Chem; 1969 Sep; 12(5):898-902. PubMed ID: 5812208
    [No Abstract]   [Full Text] [Related]  

  • 31. Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Mar; 12(2):224-7. PubMed ID: 5254099
    [No Abstract]   [Full Text] [Related]  

  • 32. The "induction" of leukocyte and erythrocyte dihydrofolate reductase by methotrexate. II. Clinical and pharmacologic studies.
    Bertino JR; Cashmore A; Fink M; Calabresi P; Lefkowitz E
    Clin Pharmacol Ther; 1965; 6(6):763-70. PubMed ID: 5846409
    [No Abstract]   [Full Text] [Related]  

  • 33. Irreversible enzyme inhibitors. CXXXV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(p-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):79-81. PubMed ID: 5763045
    [No Abstract]   [Full Text] [Related]  

  • 34. Organic disulfides and related substances. XVII. Analogs of o-(2-aminoethyldithio)benzoic acid as antiradiation drugs.
    Field L; Kim HK
    J Med Chem; 1966 May; 9(3):397-402. PubMed ID: 5960913
    [No Abstract]   [Full Text] [Related]  

  • 35. Irreversible enzyme inhibitors. CXXXVI. 2,4-Diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonylbenzamido)phenoxymethyl]pyrimidine, an active-site-directed irreversible inhibitor of dihydrofolic reductase. Effect of structure on isozyme specificity.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):82-5. PubMed ID: 5763046
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibitor binding analysis of dihydrofolate reductases from various species.
    Burchall JJ; Hitchings GH
    Mol Pharmacol; 1965 Sep; 1(2):126-36. PubMed ID: 4378654
    [No Abstract]   [Full Text] [Related]  

  • 37. Calculations by complete neglect of differential overlap (CNDO/2) on dihydrofolic acid: role of N(5) in reduction by dihydrofolate reductase.
    Gund P; Poe M; Hoogsteen KH
    Mol Pharmacol; 1977 Nov; 13(6):1111-5. PubMed ID: 593265
    [No Abstract]   [Full Text] [Related]  

  • 38. Enzyme inhibitors. 13. The synthesis of active-site-directed irreversible inhibitor of adenosine deaminase.
    Schaeffer HJ; Odin E
    J Med Chem; 1966 Jul; 9(4):576-81. PubMed ID: 5968026
    [No Abstract]   [Full Text] [Related]  

  • 39. Irreversible enzyme inhibitors. CXXXIV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
    Baker BR; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):74-8. PubMed ID: 5763044
    [No Abstract]   [Full Text] [Related]  

  • 40. Resistance to inhibitors of dihydrofolate reductase in strains of Lactobacillus casei and Proteus vulgaris.
    Singer S; Elion GB; Hitchings GH
    J Gen Microbiol; 1966 Feb; 42(2):185-96. PubMed ID: 5912585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.